OQ
LIVE

Serial Number

79452174

Owner

Otsuka Pharmaceutical Co., Ltd.

Filing Date

Mar 12, 2026

Add to watchlist:

No watchlists yet
View on USPTO

OQ Trademark

Serial Number: 79452174

OQ is a trademark filed by Otsuka Pharmaceutical Co., Ltd. on March 12, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Otsuka Pharmaceutical Co., Ltd. (568 trademarks)

Chiyoda-ku, Tokyo , JP

Entity Type: 03

Trademark Details

Filing Date

March 12, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment and prevention of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment and prevention of dermatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; pharmaceutical preparations for use as a preparatory regimen in connection with bone marrow transplants; pharmaceutical preparations for the treatment and prevention of metabolic diseases; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for inhibiting blood platelet aggregation.

Filing History

LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 29, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 18, 2026 REPR